p21-Activated Kinase 5 (Pak5) contributes to sorafenib resistance of HCC via regulatory effects on the β-catenin/ABCB1 signaling and miR-138-1-3p is downregulated in sorafenib-resistant HCC cell lines. This evidence concerns the gene PAK5 and hepatocellular carcinoma.